Ticagrelor
In vial of 0.5 g. net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Ticagrelor
Maker Name
Product Description
Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video